Hi,
Have you tried to multiplex more than 4 samples?
Have you tried to multiplex more than 4 samples?
-
-
We have used the Nimblegen solution based capture method on a target region of ~1.5Mb. Our first expt screwed up fantastically well so we've had to repeat everything from scratch and are in the process of performing the QC on our results. We did the expt in 2 ways, we chose 8 individuals, sonicated and end repaaired etc, ran our precapture PCR to introduce barcoded primers then used qPCR to quantitate the samples and added eqimolar amounts of each sample to 1 hybridisation reaction. This was subsequently cleaned and prepared for sequencing as normal. The second method involved taking the samples through the whole protocol individually and only introducing the barcodes during the post hybridisation PCR, again the samples were quantitated using qPCR and then pooled together before sequencing. The thing about our protocol is that the majority of it is automated, all the cocktail addiditions and cleaning steps (using Ampure XP) are performed on a biomek fx and nx robot meaning in theory we can process 96 samples at a time. I'll have some results over the next week or two if anyone is interested?Comment
-
Have you tried an Array-Based Capture as well?Comment
-
No we've only used solution based captureComment
-
right,
but if you could let us know anyway how did it work would be great
thanksComment
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment